March 3, 2022 -- Gyros Protein Technologies has released its PurePep Sonata+, a mid-pilot scale peptide synthesizer. The new system is an upgraded version of the company’s previous model, Sonata XT, known for its reliability and robustness, to further strengthen the company’s offering.
The upgrade, PurePep Sonata+, builds on the ability of Sonata XT through the introduction of real-time flow technology, a non-invasive method to continually monitor the flow rate of fluids within the system, which enables accurate and precise fluid transfers for a range of viscosities.
The need to calibrate is thereby minimized, and workflows that previously required one day for fluid calibration are significantly shortened. The company’s proprietary valve block system, the PurePep Pathway, is also integrated to ensure no cross-contamination, for reliable peptide purity.
With a reduced calibration time to streamline and shorten workflows, improved reliability and robustness, the new peptide synthesizer is easy to operate, and the intuitive software platform, designed for 21 Code of Federal Regulations (CFR) Part 11 compliance, facilitates an easy transition from the bench-scale PurePep Chorus to mid-pilot scale.
Gyros Protein Technologies is a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays.
Copyright © 2022 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
